Asset Allocation & Management Company’s Johnson & Johnson JNJ Stock Holding History

Asset Allocation & Management Company’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$408K	Sell	1,606 -1,068	-40%	-$249K	0.13%	50
2026 Q1	$654K	Hold	2,674	–	–	0.24%	36
2025 Q4	$553K	Hold	2,674	–	–	0.22%	42
2025 Q3	$496K	Hold	2,674	–	–	0.21%	42
2025 Q2	$408K	Hold	2,674	–	–	0.19%	55
2025 Q1	$443K	Hold	2,674	–	–	0.22%	52
2024 Q4	$387K	Buy	+2,674	New	+$414K	0.21%	52
2023 Q3	–	Sell	-3,998	Closed	-$662K	–	56
2023 Q2	$662K	Sell	3,998 -877	-18%	-$142K	0.26%	38
2023 Q1	$756K	Sell	4,875 -2,000	-29%	-$323K	0.3%	45
2022 Q4	$1.21M	Sell	6,875 -1,521	-18%	-$263K	0.47%	28
2022 Q3	$13.7M	Buy	8,396 +4	+0%	+$677	5.62%	6
2022 Q2	$1.49M	Hold	8,392	–	–	0.62%	20
2022 Q1	$1.49M	Hold	8,392	–	–	0.53%	30
2021 Q4	$1.44M	Buy	+8,392	New	+$1.37M	0.49%	29
2020 Q1	–	Sell	-1,579	Closed	-$230K	–	56
2019 Q4	$230K	Buy	+1,579	New	+$214K	0.09%	54

Other funds holding JNJ

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AACR

ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Asset Allocation & Management Company's JNJ Position: Q2 2026 in Review

Asset Allocation & Management Company reduced its Johnson & Johnson (JNJ) stake by 40% in Q2 2026, selling an estimated $249K and leaving 1,606 shares worth $408K. The position accounts for 0.13% of the portfolio, ranked #50.

Asset Allocation & Management Company first reported a position in JNJ in Q4 2019 and has held it in 15 quarters since. The position peaked at $13.7M in Q3 2022. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Asset Allocation & Management Company held 1,606 shares of Johnson & Johnson worth $408K as of Q2 2026.
Asset Allocation & Management Company sold 1,068 Johnson & Johnson shares in Q2 2026, an estimated $249K.
Johnson & Johnson made up 0.13% of Asset Allocation & Management Company's portfolio in Q2 2026, its #50 holding.
Asset Allocation & Management Company first reported a position in Johnson & Johnson in Q4 2019 and has held it in 15 quarters since.
Asset Allocation & Management Company's Johnson & Johnson position peaked at $13.7M in Q3 2022.
2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Asset Allocation & Management Company's 13F filing for Q2 2026, filed 15 Jul 2026.